Clinical Experience with Naltrexone
Abstract
(1975). Clinical Experience with Naltrexone. The American Journal of Drug and Alcohol Abuse: Vol. 2, No. 3-4, pp. 365-377.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Patient adherence and drop-out have been a major stumbling block for oral naltrexone.
“Patient adherence and drop out has been a major stumbling block for oral naltrexone.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [113]
Cites
Naltrexone, an Antagonist for the Treatment of Heroin Dependence
Martin, W. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360022003 · Cited by 393 · see citing works
Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist
Resnick, R. B., Volavka, J., Freedman, A. M., & THOMAS, M. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.6.646 · Cited by 197 · see citing works
Naloxone treatment of opiate dependence. A progress report
Zaks, A. (1971) · JAMA · doi:10.1001/jama.215.13.2108 · Cited by 78 · see citing works
Cyclazocine treatment of opiate dependence: A progress report
Resnick, R. B., Fink, M., & Freedman, A. M. (1971) · Comprehensive Psychiatry · doi:10.1016/0010-440x(71)90031-9 · Cited by 44 · see citing works
Cyclazocine, an Adjunct in the Treatment of Narcotic Addiction
Martin, W. R., & Gorodetzky, C. W. (1967) · International Journal of the Addictions · doi:10.3109/10826086709074412 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · see citing works
Self-citationMaintenance Medication for Opiate Addiction: The Foundation of Recovery
Bart, G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.694598 · Cited by 461 · see citing works
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub4 · Cited by 432 · see citing works
(2001) · Survey of Anesthesiology · doi:10.1097/00132586-200108000-00061 · Cited by 358 · see citing works
Gonzalez, J. P., & Brogden, R. N. (1988) · Drugs · doi:10.2165/00003495-198835030-00002 · Cited by 315 · see citing works
Controversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270 · see citing works
Critical assessment of how to study addiction and its treatment: Human and non-human animal models
O’Brien, C. P., & Gardner, E. L. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.018 · Cited by 221 · see citing works
Self-citationNaltrexone pharmacotherapy for opioid dependent federal probationers
Cornish, J., Metzger, D. S., WOODY, G. E., Wilson, D., McLellan, A. T., Vandergrift, B., & O’Brien, C. P. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00020-2 · Cited by 211 · see citing works
Self-citationDepot naltrexone: long-lasting antagonism of the effects of heroin in humans
Comer, S., Collins, E., Kleber, H., Nuwayser, E., Kerrigan, J., & Fischman, M. (2002) · Psychopharmacology · doi:10.1007/s002130100909 · Cited by 175 · see citing works
Self‐injurious behavior and the efficacy of naltrexone treatment: A quantitative synthesis
Symons, F. J., Thompson, A. L., & Rodriguez, M. C. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20031 · Cited by 161 · see citing works
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub3 · Cited by 151 · see citing works
A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence
Kirchmayer, U., Davoli, M., Verster, A. D., Amato, L., Ferri, A., & Perucci, C. A. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00217.x · Cited by 106 · see citing works
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub2 · Cited by 106 · see citing works
Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
Krupitsky, E., Zvartau, E., Masalov, D., Tsoi, M.-V., Burakov, A., Egorova, V., Didenko, T., Romanova, T., Ivanova, E. B., Bespalov, A., et al. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.02.002 · Cited by 103 · see citing works
Self-citationKrupitsky, E. M., Zvartau, E. E., Masalov, D. V., Tsoy, M. V., Burakov, A. M., Egorova, V. Y., Didenko, T. Y., Romanova, T. N., Ivanova, E. B., Bespalov, A. Y., et al. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.05.005 · Cited by 93 · see citing works
Self-citationPredictors of favorable outcome following naltrexone treatment
Greenstein, R. A., Evans, B. D., McLellan, A. T., & O’Brien, C. P. (1983) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(83)90042-x · Cited by 88 · see citing works
Self-citationNaltrexone Implants Compared to Methadone: Outcomes Six Months after Prison Release
Lobmaier, P. P. K., Kunøe, N., Gossop, M., Katevoll, T., & Waal, H. (2010) · European Addiction Research · doi:10.1159/000313336 · Cited by 82 · see citing works
Mu Opioid Receptor Antagonists: Recent Developments
Goodman, A. J., Bourdonnec, B. L., & Dolle, R. E. (2007) · ChemMedChem · doi:10.1002/cmdc.200700143 · Cited by 84 · see citing works
The efficacy of naltrexone in preventing reabuse of heroin after detoxification
Shufman, E., Porat, S., Witztum, E., Gandacu, D., Bar‐Hamburger, R., & Ginath, Y. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91240-8 · Cited by 84 · see citing works
Rascol, O., Fabre, N., Blin, O. J., Poulik, J. M., Sabatini, U., Sénard, J., Ané, M., Montastruc, J., & Rascol, A. (1994) · Movement Disorders · doi:10.1002/mds.870090410 · Cited by 82 · see citing works
Naltrexone treatment of heroin addiction: Efficacy and safety in a double-blind dosage comparison
Judson, B. A., Carney, T. M., & Goldstein, A. (1981) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(81)90049-1 · Cited by 66 · see citing works
Rabinowitz, J., Cohen, H., Tarrasch, R., & Kotler, M. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00073-2 · Cited by 66 · see citing works
Catafau, A. M., Etcheberrigaray, A., Cobos, J. P. D. L., Estorch, M., Guardia, J., Flotats, A., Bernà, L., Aparici, C. M., Casas, M., & Carrió, I. (1999) · PubMed · Cited by 63 · see citing works
Coviello, D. M., Cornish, J. W., Lynch, K. G., Boney, T. Y., Clark, C. A., Lee, J. D., Friedmann, P. D., Nunes, E. V., Kinlock, T. W., Gordon, M. S., et al. (2012) · Substance Abuse · doi:10.1080/08897077.2011.609438 · Cited by 58 · see citing works
Self-citationBehavioral pharmacology of buprenorphine
Mello, N. K., & Mendelson, J. H. (1985) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(85)90062-6 · Cited by 52 · see citing works
A Randomized Trial of Oral Naltrexone for Treating Opioid‐Dependent Offenders
Coviello, D. M., Cornish, J. W., Lynch, K. G., Alterman, A. I., & O’Brien, C. P. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00070.x · Cited by 50 · see citing works
Self-citationYuan, Y., Zaidi, S. A., Elbegdorj, O., Aschenbach, L. C., Guo, L., Stevens, D. L., Scoggins, K. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012214 · Cited by 47 · see citing works
Naltrexone maintenance treatment for opioid dependence
Kirchmayer, U., Davoli, M., & Verster, A. D. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333 · Cited by 47 · see citing works
Naltrexone for probationers and parolees
O’Brien, C. P., & Cornish, J. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.06.002 · Cited by 44 · see citing works
Self-citationNaltrexone in the treatment of heroin dependence: a literature review
Tucker, T., & Ritter, A. J. (2000) · Drug and Alcohol Review · doi:10.1080/09595230096174 · Cited by 44 · see citing works
Treating drug misuse problems : evidence of effectiveness.
Gossop, M. (2006) · Europe PMC (PubMed Central) · Cited by 41 · see citing works
Naltrexone: A Short-Term Treatment for Opiate Dependence
Greenstein, R. A., O’Brien, C. P., McLellan, A. T., WOODY, G. E., Grabowski, J., Long, M., Coyle-Perkins, G., & Vittor, A. (1981) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998109009554 · Cited by 41 · see citing works
Self-citationThe Treatment of Heroin Addiction: Naltrexone Alone and with Behavior Therapy
Callahan, E. J., Rawson, R. A., McCleave, B., Arias, R., Glazer, M., & Liberman, R. P. (1980) · International Journal of the Addictions · doi:10.3109/10826088009040057 · Cited by 41 · see citing works
CLINICAL PHARMACOLOGY OF NARCOTIC ANTAGONISTS*
O’Brien, C. P., Greenstein, R. A., Ternes, J. W., & WOODY, G. E. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb16779.x · Cited by 35 · see citing works
Self-citationLong-Acting Injectable naltrexone for the Management of patients with Opioid Dependence
Kjome, K. L., & Moeller, F. G. (2011) · Substance Abuse Research and Treatment · doi:10.4137/sart.s5452 · Cited by 34 · see citing works
Naltrexone maintenance for heroin dependence: uptake, attrition and retention
Tucker, T., Ritter, A. J., Maher, C., & Jackson, H. J. (2004) · Drug and Alcohol Review · doi:10.1080/09595230412331289464 · Cited by 33 · see citing works
The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey
Killian, A. K., Bonese, K., & Schuster, C. R. (1978) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(78)90078-9 · Cited by 33 · see citing works
Lawental, E. (2000) · Journal of Substance Abuse · doi:10.1016/s0899-3289(00)00019-5 · Cited by 30 · see citing works
Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
Mannelli, P., Peindl, & Wu, L.-T. T. (2011) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s15853 · Cited by 30 · see citing works
The Role of Narcotic Antagonists in the Rehabilitation of Opiate Addicts: A Review of Naltrexone
Schecter, A. J. (1980) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998009028406 · Cited by 29 · see citing works
Ma, H., Obeng, S., Wang, H., Zheng, Y., Li, M., Jali, A. M., Stevens, D. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01767 · Cited by 24 · see citing works
Naltrexone Implant for Opioid Use Disorder
Edinoff, A. N., Nix, C. A., Orellana, C. V., StPierre, S., Crane, E. A., Bulloch, B. T., Cornett, E. M., Kozinn, R. L., Kaye, A. M., Murnane, K. S., et al. (2021) · Neurology International · doi:10.3390/neurolint14010004 · Cited by 24 · see citing works
Pagare, P. P., Li, M., Zheng, Y., Kulkarni, A. S., Obeng, S., Huang, B., Ruiz, C., Gillespie, J. C., Mendez, R. E., Stevens, D. L., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00087 · Cited by 26 · see citing works
Narcotic Antagonist Treatment: Clinical Experience with Naltrexone
Lewis, D. C., Mayer, J. E., Hersch, R. G., & Black, R. (1978) · International Journal of the Addictions · doi:10.3109/10826087809039316 · Cited by 23 · see citing works
Blum, K., Lott, L., Baron, D. A., Smith, D. E., Badgaiyan, R. D., & Gold, M. S. (2020) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000229 · Cited by 21 · see citing works
6‐β‐Naltrexol Reduces Alcohol Consumption in Rats
Rukstalis, M. R., Stromberg, M. F., O’Brien, C. P., & Volpicelli, J. R. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04580.x · Cited by 20 · see citing works
Self-citationPagare, P. P., Flammia, R., & Zhang, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107023 · Cited by 18 · see citing works
Mitchem, L. D., Kruschel, C. K., Dallman, E., Anders, K. A., Czapiga, M., Panos, J., & Steinpreis, R. E. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00150-6 · Cited by 18 · see citing works
Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals
Price, R. C., Christou, N. V., Backman, S. B., Stone, L. S., & Schweinhardt, P. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4417-4 · Cited by 15 · see citing works
Effects of Long-Term Treatment with Naltrexone on Hepatic Enzyme Activity
Pini, L. A., Ferretti, C., Trenti, T., Ferrari, A., & Sternieri, E. (1991) · Drug metabolism and drug interactions · doi:10.1515/dmdi.1991.9.2.161 · Cited by 15 · see citing works
Ma, H., Pagare, P. P., Li, M., Neel, L. T., Mendez, R. E., Gillespie, J. C., Stevens, D. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01499 · Cited by 14 · see citing works
Research and development of naltrexone: a new narcotic antagonist
Julius, D. A. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.6.782 · Cited by 14 · see citing works
Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers
Cornish, J., Henson, D., Levine, S., Volpicelli, J. R., Inturrisi, C. E., Yoburn, B. C., & O’Brien, C. P. (1993) · American Journal on Addictions · doi:10.3109/10550499309115940 · Cited by 13 · see citing works
Self-citationKreek, M. J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_15 · Cited by 13 · see citing works
Pagare, P. P., Obeng, S., Huang, B., Marcus, M. M., Nicholson, K. L., Townsend, A. E., Banks, M. L., & Zhang, Y. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00178 · Cited by 10 · see citing works
Manual for Primary Care Providers: Effectively Caring for Active Substance Users
Finkelstein, R., & Ramos, S. E. (2002) · Cited by 9 · see citing works
Is Addiction an Illness—Can it be Treated?
McLellan, A. T. (2002) · Substance Abuse · doi:10.1080/08897070209511508 · Cited by 8 · see citing works
Treatments for Opiate Dependence
WOODY, G. E., O’Brien, C. P., & McLellan, A. T. (1984) · Psychiatric Annals · doi:10.3928/0048-5713-19840401-08 · Cited by 8 · see citing works
Self-citationCurrent Progress in Opioid Treatment
WOODY, G. E. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16121398 · Cited by 5 · see citing works
Self-citationThompson, T. I., Zarcone, J. R., & Symons, F. J. (2004) · Wiley eBooks · doi:10.1002/9780470713198.ch28 · Cited by 5 · see citing works
BEHAVIORAL ASSESSMENT AND TREATMENT EVALUATION OF NARCOTIC ADDICTION
Callahan, E. J., & Rawson, R. A. (1980) · Elsevier eBooks · doi:10.1016/b978-0-08-022997-3.50010-7 · Cited by 5 · see citing works
Pharmacotherapy of narcotic dependence
Maykut, M. O. (1977) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(77)90026-1 · Cited by 4 · see citing works
The Role of Naltrexone in the Treatment of Opioid Dependence
O’Brien, C. P., & WOODY, G. E. (1986) · Springer eBooks · doi:10.1007/978-1-4615-7743-0_7 · Cited by 4 · see citing works
Self-citationMostallino, R., Caria, F., Musa, A., Piras, G., Ture, A., Vanejevs, M., Laus, A., Tocco, G., Chiara, G. D., Castelli, M. P., et al. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174060 · Cited by 3 · see citing works
Cornish, J., Henson, D., Levine, S., Volpicelli, J. R., Inturrisi, C. E., Yoburn, B. C., & O’Brien, C. P. (1993) · American Journal on Addictions · doi:10.1111/j.1521-0391.1993.tb00368.x · Cited by 3 · see citing works
Self-citationSchwartz, R. P., Mitchell, S. G., Gordon, M., & Kinlock, T. W. (2011) · Issues in children's and families' lives · doi:10.1007/978-1-4419-9470-7_15 · Cited by 2 · see citing works
Naltrexone and Conventionality
Suffet, F., Remine, D. C., Taleporos, E., & Brotman, R. (1978) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952997809028000 · Cited by 2 · see citing works
Mangado, E. O., & Madoz‐Gúrpide, A. (2005) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1 · see citing works
Madoz‐Gúrpide, A., Ochoa, E., Salvador, E., & Baca‐García, E. (2003) · Adicciones · doi:10.20882/adicciones.448 · Cited by 1 · see citing works
Naltrexone: Current Clinical Investigations
Ginzburg, H. M., & Markowitz, R. A. (1984) · Springer eBooks · doi:10.1007/978-94-011-6320-0_15
CLINICAL MANAGEMENT OF DRUG DEPENDENCE: PHARMACOTHERAPEUTIC ASPECTS
Maykut, M. O. (1978) · Elsevier eBooks · doi:10.1016/b978-1-4832-8322-7.50052-2
Madoz‐Gúrpide, A., Mangado, E. O., & Baca‐García, E. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)73411-8 · Cited by 1 · see citing works
Bart, G. B. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
Opiates and Prescription Drugs
Renner, J. A., & Suzuki, J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_21
Lobmaier, P. P. K. (2010) · NORA - Norwegian Open Research Archives
Naltrexone: Factors Contributing to Retention in Treatment
Greenstein, R. A., Grabowski, J., O’Brien, C. P., Long, M., WOODY, G. E., & Livingston, S. J. (1981) · Springer eBooks · doi:10.1007/978-1-4684-3614-3_122
Self-citationEinsatz von Opioidantagonisten in der abstinenzerhaltenden Behandlung der Opiatabhängigkeit
Kiefer, F. W. (2004) · Suchttherapie · doi:10.1055/s-2004-813163
O’Brien, C. P. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.006
Self-citationTsoy-Podosenin, M., & Krupitsky, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.38
Flammia, R., Huang, B., Pagare, P. P., Onge, C. M. S., Abebayehu, A., Gillespie, J. C., Mendez, R. E., Selley, D. E., Dewey, W. L., & Zhang, Y. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107489
Redondo, C. L., Solli, K. K., Benth, J. Š., Mordal, J., Tanum, L., & Weimand, B. M. (2026) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2026.101042
- Authors
- O'brien, C. P., Greenstein, R. A., Mintz, J., & Woody, G. E.
- Affiliations
- United States Department of Veterans Affairs (US)
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 1975-01
- Volume
- 2
- Issue
- 3-4
- Pages
- 365-377
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- OpenAlex
- W2010510682
- Cited by
- 82
- References
- 5
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2013: 2 · 2012: 3
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Drug and Alcohol Abuse (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- naltrexone, opioid antagonists, opioid use disorder, alcoholism treatment, addiction treatment
- MeSH terms
- Administration, Oral, Adult, Female, Heroin Dependence, Hospitalization, Humans, Male, Methadone, Middle Aged, Morphine, Naloxone, Naltrexone, Outpatient Clinics, Hospital, Patient Dropouts, Placebos, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
